Old Mutual Customised Solutions’s Alexion Pharmaceuticals ALXN Stock Holding History

Old Mutual Customised Solutions’s Portfolio ALXN Stock Details ALXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	$404K	Hold	3,258	–	–	0.04%	441
2018 Q1	$363K	Hold	3,258	–	–	0.04%	450
2017 Q4	$390K	Hold	3,258	–	–	0.04%	443
2017 Q3	$457K	Hold	3,258	–	–	0.06%	353
2017 Q2	$396K	Sell	3,258 -4,500	-58%	-$524K	0.06%	365
2017 Q1	$941K	Buy	7,758 +2,058	+36%	+$265K	0.15%	175
2016 Q4	$697K	Buy	5,700 +2,200	+63%	+$269K	0.13%	203
2016 Q3	$429K	Hold	3,500	–	–	0.12%	194
2016 Q2	$409K	Hold	3,500	–	–	0.1%	238
2016 Q1	$487K	Hold	3,500	–	–	0.13%	196
2015 Q4	$668K	Hold	3,500	–	–	0.17%	139
2015 Q3	$547K	Buy	3,500 +500	+17%	+$91.2K	0.15%	175
2015 Q2	$542K	Buy	3,000 +600	+25%	+$104K	0.13%	186
2015 Q1	$416K	Buy	2,400 +2,100	+700%	+$380K	0.1%	247
2014 Q4	$56K	Buy	300 +200	+200%	+$37.1K	0.02%	637
2014 Q3	$17K	Sell	100 -500	-83%	-$82.1K	﹤0.01%	678
2014 Q2	$94K	Sell	600 -300	-33%	-$47.4K	0.02%	614
2014 Q1	$137K	Buy	900 +200	+29%	+$31.8K	0.03%	520
2013 Q4	$93K	Sell	700 -300	-30%	-$36K	0.02%	612
2013 Q3	$116K	Buy	1,000 +400	+67%	+$43.9K	0.03%	545
2013 Q2	$55K	Buy	+600	New	+$57.8K	0.02%	691

Other funds holding ALXN

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Old Mutual Customised Solutions's ALXN Position: Q2 2018 in Review

Old Mutual Customised Solutions held its Alexion Pharmaceuticals (ALXN) position steady in Q2 2018 at 3,258 shares worth $404K. The position accounts for 0.04% of the portfolio, ranked #441.

Old Mutual Customised Solutions first reported a position in ALXN in Q2 2013 and has held it in 21 quarters since. The position peaked at $941K in Q1 2017. 601 funds tracked by Wall St. Rank hold ALXN as of Q2 2018.

Old Mutual Customised Solutions held 3,258 shares of Alexion Pharmaceuticals worth $404K as of Q2 2018.
Old Mutual Customised Solutions left its Alexion Pharmaceuticals share count unchanged in Q2 2018.
Alexion Pharmaceuticals made up 0.04% of Old Mutual Customised Solutions's portfolio in Q2 2018, its #441 holding.
Old Mutual Customised Solutions first reported a position in Alexion Pharmaceuticals in Q2 2013 and has held it in 21 quarters since.
Old Mutual Customised Solutions's Alexion Pharmaceuticals position peaked at $941K in Q1 2017.
601 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q2 2018.

Based on Old Mutual Customised Solutions's 13F filing for Q2 2018, filed 14 Aug 2018.